Found: 8
Select item for more details and to access through your institution.
Molecular basis of dopamine replacement therapy and its side effects in Parkinson’s disease.
- Published in:
- Cell & Tissue Research, 2018, v. 373, n. 1, p. 111, doi. 10.1007/s00441-018-2813-2
- By:
- Publication type:
- Article
A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: A randomized crossover clinical trial.
- Published in:
- Annals of Neurology, 2011, v. 69, n. 1, p. 111, doi. 10.1002/ana.22155
- By:
- Publication type:
- Article
Three to four mRNA COVID‐19 vaccines in multiple sclerosis patients on immunosuppressive drugs: Seroconversion and variant neutralization.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 9, p. 2781, doi. 10.1111/ene.15925
- By:
- Publication type:
- Article
Correction: Bee Venom for the Treatment of Parkinson Disease – A Randomized Controlled Clinical Trial.
- Published in:
- 2016
- By:
- Publication type:
- Correction Notice
Bee Venom for the Treatment of Parkinson Disease – A Randomized Controlled Clinical Trial.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0158235
- By:
- Publication type:
- Article
The autophagy/lysosome pathway is impaired in SCA7 patients and SCA7 knock-in mice.
- Published in:
- Acta Neuropathologica, 2014, v. 128, n. 5, p. 705, doi. 10.1007/s00401-014-1289-8
- By:
- Publication type:
- Article
Gene Expression Analyses Identify Narp Contribution in the Development of L-DOPA-Induced Dyskinesia.
- Published in:
- Journal of Neuroscience, 2015, v. 35, n. 1, p. 96, doi. 10.1523/JNEUROSCI.5231-13.2015
- By:
- Publication type:
- Article